Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of SLITRK3 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse |
| Host species | Rabbit |
| Applications | WB-Ce,IHC-P |
More info about SLITRK3 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB13331 |
| Product name: | SLITRK3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of SLITRK3. |
| Gene id: | 22865 |
| Gene name: | SLITRK3 |
| Gene alias: | KIAA0848|MGC138681 |
| Gene description: | SLIT and NTRK-like family, member 3 |
| Immunogen: | A synthetic peptide corresponding to C-terminus 14 amino acids of human SLITRK3. |
| Protein accession: | O94933 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.02% sodium azide) |
| Storage instruction: | Store at 4°C for three months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse |
| Application image: |  |
| Application image note: | Immunohistochemistry of SLITRK3 in human brain tissue with SLITRK3 polyclonal antibody (Cat # PAB13331) at 2.5 ug/mL . |
| Applications: | WB-Ce,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth.Aruga J, Mikoshiba K. Mol Cell Neurosci. 2003 Sep;24(1):117-29. |